Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 5Polycystic Ovary Syndrome 3Neoplasm Metastasis 2Leiomyoma 2Vaginitis 1Triple Negative Breast Neoplasms 1Prostatic Neoplasms 1Pregnancy Complications 1Menorrhagia 1Estrogen Receptor Positive Breast Cancer 1Endometriosis 1Atrophic Vaginitis 1Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Metformin 21Inositol 13Letrozole 9Exercise 5Surveys and Questionnaires 4Clomiphene 4Tablets 3Estradiol 3semaglutide 2maltodextrin 2drospirenone and ethinyl estradiol combination 2Spironolactone 2Progesterone 2Ethinyl Estradiol 2Diet Therapy 2Contraceptives, Oral, Combined 2Caloric Restriction 2Acupuncture Therapy 2salicylsalicylic acid 1mirabegron 1etonogestrel 1drospirenone 1dapagliflozin 1cetrorelix 1Walking 1Tirzepatide 1Thyroxine 1Thioctic Acid 1Tamoxifen 1Sodium-Glucose Transporter 2 Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Polycystic Ovary Syndrome × Estradiol × 1 year × Clear all
NCT07379502 2026-01-30

Endometrial Response in Polycystic Ovarian Syndrome Treated With Letrozole Alone or With Added Estradiol Valerate

CMH Kharian Medical College

Phase NA Not yet recruiting
60 enrolled

Polycystic Ovary Syndrome

NCT03043924 2025-12-11

MRI-PCOS

University Hospital, Lille

Phase NA Completed
52 enrolled

Polycystic Ovary Syndrome

NCT03401047 2025-08-05

CRM009

University of Virginia

Phase EARLY_PHASE1 Recruiting
37 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡